Niche Topoisomerase Target niche: TopoGEN focuses on topoisomerases for drug discovery and research, presenting a specialized opportunity to upsell assay kits, DNA substrates, inhibitors, and complete screening services to cancer and antibacterial research teams.

In House screening Sales angle: Their in house, mechanism based cell based screens for topoisomerase poisons position TopoGEN as a preferred provider for contract screening, enabling partnerships around customized, high-value screening projects and data interpretation services.

Global longstanding Market entry: A global, long-standing client base since the 1990s suggests stability and potential for expanding product adoption across labs already familiar with their topoisomerase tools, reagents, and support services.

Colorado expansion Growth signal: Recent office expansion in Colorado indicates capacity growth and potential for increased service capacity, enabling scalable offerings to researchers expanding cancer and antimicrobial topoisomerase programs.

Small team leverage Sales opportunity: With a lean team of 2-10 employees, there is an opportunity to position high-touch, value-added partnerships, retainer consults, and bundled kits for efficient procurement to maximize revenue per account.